SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTO
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN KOLNIK who wrote (7147)4/1/1998 4:37:00 PM
From: John Hensley  Read Replies (2) of 8116
 
This is from today's Wall Street Journal interactive addition (note the absence of CYTO):

After Monday's close, Dupont Merck Pharmaceutical, a research venture
of DuPont and Merck, said a new published study confirmed its
cancer-therapy agent Quadramet provides "significant pain relief" from
metastatic prostate and breast cancer spread to the bone. Merck rose 1
15/16 to 128 3/16; DuPont fell 3/4 to 68.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News